<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30445651</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>16</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1460-2105</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>15</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of the National Cancer Institute</Title>                <ISOAbbreviation>J. Natl. Cancer Inst.</ISOAbbreviation>            </Journal>            <ArticleTitle>Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1093/jnci/djy173</ELocationID>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Hormone receptor signaling is critical in the progression of breast cancers, although the role of the androgen receptor (AR) remains unclear, particularly for estrogen receptor (ER)-negative tumors. This study assessed AR protein expression as a prognostic marker for breast cancer mortality.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">This study included 4147 pre- and postmenopausal women with invasive breast cancer from the Nurses' Health Study (diagnosed 1976-2008) and Nurses' Health Study II (1989-2008) cohorts. AR protein expression was evaluated by immunohistochemistry and scored through pathologist review and as a digitally quantified continuous measure. Hazard ratios (HR) and 95% confidence intervals (CI) of breast cancer mortality were estimated from Cox proportional hazards models, adjusting for patient, tumor, and treatment covariates.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Over a median 16.5 years of follow-up, there were 806 deaths due to breast cancer. In the 7 years following diagnosis, AR expression was associated with a 27% reduction in breast cancer mortality overall (multivariable HR = 0.73, 95% CI = 0.58 to 0.91) a 47% reduction for ER+ cancers (HR = 0.53, 95% CI = 0.41 to 0.69), and a 62% increase for ER- cancers (HR = 1.62, 95% CI = 1.18 to 2.22) (P heterogeneity &lt; .001). A log-linear association was observed between AR expression and breast cancer mortality among ER- cancers (HR = 1.14, 95% CI = 1.02 to 1.26 per each 10% increase in AR), although no log-linear association was observed among ER+ cancers.</AbstractText>                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">AR expression was associated with improved prognosis in ER+ tumors and worse prognosis in ER- tumors in the first 5-10 years postdiagnosis. These findings support the continued evaluation of AR-targeted therapies for AR+/ER- breast cancers.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kensler</LastName>                    <ForeName>Kevin H</ForeName>                    <Initials>KH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Poole</LastName>                    <ForeName>Elizabeth M</ForeName>                    <Initials>EM</Initials>                    <AffiliationInfo>                        <Affiliation>Sanofi Genzyme, Cambridge, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Heng</LastName>                    <ForeName>Yujing J</ForeName>                    <Initials>YJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Collins</LastName>                    <ForeName>Laura C</ForeName>                    <Initials>LC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Glass</LastName>                    <ForeName>Benjamin</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>PathAI, Cambridge, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Beck</LastName>                    <ForeName>Andrew H</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>PathAI, Cambridge, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hazra</LastName>                    <ForeName>Aditi</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rosner</LastName>                    <ForeName>Bernard A</ForeName>                    <Initials>BA</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Eliassen</LastName>                    <ForeName>A Heather</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hankinson</LastName>                    <ForeName>Susan E</ForeName>                    <Initials>SE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics and Epidemiology, University of Massachusetts School of Public Health and Health Sciences, Amherst, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Winer</LastName>                    <ForeName>Eric P</ForeName>                    <Initials>EP</Initials>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brown</LastName>                    <ForeName>Myles</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tamimi</LastName>                    <ForeName>Rulla M</ForeName>                    <Initials>RM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School, Boston, MA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>15</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Natl Cancer Inst</MedlineTA>            <NlmUniqueID>7503089</NlmUniqueID>            <ISSNLinking>0027-8874</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30445651</ArticleId>            <ArticleId IdType="pii">5184399</ArticleId>            <ArticleId IdType="doi">10.1093/jnci/djy173</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>